In recent years, transcatheter intervention techniques have emerged as a promising alternative for the closure of perimembranous ventricular septal defect (VSD). The advancements in trancatheter VSD ...

September 18, 2007 — The US Food and Drug Administration (FDA) has granted 510(k) clearance to 2 flexible digital endoscopes for diagnostic and therapeutic procedures and to a short-term catheter for ...

SINCE the advent of open-heart surgery ventricular septal defects have become a surgically correctable anomaly. Surgeons, in their understandable enthusiasm, have recommended early repair of these ...

Chicago, IL - A nonrandomized trial of a new ventricular septal occluder designed specifically for the closure of defects that occur post-MI suggests that while mortality is still high following the ...

This paper presents serial cardiac-catheterization data showing spontaneous functional closure of large symptomatic defects in 3 infants. One had an associated moderate-sized patent ductus arteriosus ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...

Ventricular septal defect (VSD) is a birth defect in babies that causes a hole in the wall (or septum) between a baby’s lower heart chambers. Heart chambers are also called right and left ventricles.

A ventricular septal defect (VSD) is a hole in the septum, which is the wall separating the two lower chambers of the heart. In many cases, the hole closes on its own. A ventricular septal defect is a ...